Analyst consensus rating
BioStem Technologies, Inc. Analyst Consensus Rating
BSEM analyst consensus rating, coverage count and price target evidence.
Direct answer
BioStem Technologies, Inc.'s consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.00.
Forecast evidence checked August 15, 2026.
Get free BioStem Technologies, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.21
- Average price target
- $7.00
- High price target
- $7.00
- Low price target
- $7.00
- Target upside
- +118.1%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- August 15, 2026
- Valid through
- August 22, 2026